#5 - Amber Trivedi, COO at Blue Note Therapeutics
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
#5 - Amber Trivedi, COO at Blue Note Therapeutics
-
Narrated by:
-
By:
About this listen
Welcome to DTx Equals, the show where thought-leaders in digital therapeutics put a stake in the ground about what makes DTx, DTx.
Our Guest Today: Amber Trivedi, COO at Blue Note Therapeutics
What you'll get out of this episode:
- What is a formative event in your life or career that influenced your path into DTx?
- DTx equals what? What is the most defining issue of DTx today?
- How much of the problems with DTx getting reimbursment are around pricing? Do you think prices are being set too high, or do you think healthcare needs to readjust?
- Are there places where healthcare can be disentangled from a human provider?
- Where do you feel non-human DTx models really shine?
- In your wildness dreams, what is something DTx will be able to do in the future that it can’t do today?
To learn more about Amber Trivedi and Blue Note Therapeutics please use the links below:
- Amber's LinkedIn - Blue Note Therapeutics LinkedIn - Blue Note Therapeutics Website
Also, be sure to follow DTx Equals on our social channels:
- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.